EDESA BIOTECH, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
EDESA BIOTECH, INC. (EDSA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$209.22 thousand for the 9-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-09
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$76.77K.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$43.22K, a 101.48% decline year-over-year.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$89.23K.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$2.10M.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $557.41K, a 355.14% increase from fiscal 2015.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $122.47K.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$5.75M.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$9.54K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 1 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 1 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$76.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | -$119.99K derived: sum of 2 quarters · filed 2017-08-09 | -$209.22K 10-Q · filed 2017-08-09 | -$2.31M derived: sum of 4 quarters · filed 2017-08-09 | ||||||
| 2017-03-31 | -$43.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | -$132.45K 10-Q · filed 2017-05-09 | -$2.23M derived: sum of 3 quarters · filed 2017-05-09 | -$2.33M derived: sum of 4 quarters · filed 2017-08-09 | ||||||
| 2016-12-31 | -$89.23K 10-Q · filed 2017-02-06 | -$2.19M derived: sum of 2 quarters · filed 2017-02-06 | -$2.28M derived: sum of 3 quarters · filed 2017-08-09 | $644.83K derived: sum of 4 quarters · filed 2017-08-09 | ||||||
| 2016-09-30 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | -$2.20M derived: sum of 2 quarters · filed 2017-08-09 | $734.06K derived: sum of 3 quarters · filed 2017-08-09 | $557.41K 10-K · filed 2016-12-14 | ||||||
| 2016-06-30 | -$98.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $2.83M derived: sum of 2 quarters · filed 2017-08-09 | $2.65M 10-Q · filed 2017-08-09 | $2.57M derived: sum of 4 quarters · filed 2017-08-09 | ||||||
| 2016-03-31 | $2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | $2.75M 10-Q · filed 2017-05-09 | $2.67M derived: sum of 3 quarters · filed 2017-05-09 | $2.52M derived: sum of 4 quarters · filed 2017-05-09 | ||||||
| 2015-12-31 | -$176.65K 10-Q · filed 2017-02-06 | -$257.76K derived: sum of 2 quarters · filed 2017-02-06 | -$414.26K derived: sum of 3 quarters · filed 2017-02-06 | -$457.02K derived: sum of 4 quarters · filed 2017-02-06 | ||||||
| 2015-09-30 | -$81.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | -$237.61K derived: sum of 2 quarters · filed 2016-12-14 | -$280.37K derived: sum of 3 quarters · filed 2016-12-14 | $122.47K 10-K · filed 2016-12-14 | ||||||
| 2015-06-30 | -$156.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$199.26K derived: sum of 2 quarters · filed 2016-08-09 | $203.58K 10-Q · filed 2016-08-09 | $216.29K 10-Q · filed 2015-08-10 | ||||||
| 2015-03-31 | -$42.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | $360.08K 10-Q · filed 2016-05-09 | $367.12K 10-Q · filed 2015-05-11 | |||||||
| 2014-12-31 | $402.84K 10-Q · filed 2016-02-08 | $404.06K 10-Q · filed 2015-02-09 | ||||||||
| 2014-09-30 | -$13.15K 10-K · filed 2016-12-14 | -$15.97K 10-Q · filed 2015-02-09 | ||||||||
| 2014-08-31 | -$5.75M 10-K · filed 2016-12-14 | -$741.41K 10-K · filed 2014-11-21 | ||||||||
| 2014-06-30 | -$27.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | -$69.27K derived: sum of 2 quarters · filed 2015-08-10 | -$278.40K 10-Q · filed 2015-08-10 | |||||||
| 2014-03-31 | -$41.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | -$250.67K 10-Q · filed 2015-05-11 | ||||||||
| 2013-12-31 | -$209.13K 10-Q · filed 2015-02-09 | |||||||||
| 2013-08-31 | -$9.54K 10-K · filed 2015-12-14 | |||||||||
| 2012-08-31 | -$78.34K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |